FR05C0030I2 - HETEROCYCLIC AZAHEXANE DERIVATIVES WITH ANTIVIRAL ACTIVITY - Google Patents

HETEROCYCLIC AZAHEXANE DERIVATIVES WITH ANTIVIRAL ACTIVITY

Info

Publication number
FR05C0030I2
FR05C0030I2 FR05C0030C FR05C0030C FR05C0030I2 FR 05C0030 I2 FR05C0030 I2 FR 05C0030I2 FR 05C0030 C FR05C0030 C FR 05C0030C FR 05C0030 C FR05C0030 C FR 05C0030C FR 05C0030 I2 FR05C0030 I2 FR 05C0030I2
Authority
FR
France
Prior art keywords
antiviral activity
heterocyclic
azahexane derivatives
heterocyclic azahexane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR05C0030C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27171723&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR05C0030(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of FR05C0030I1 publication Critical patent/FR05C0030I1/fr
Application granted granted Critical
Publication of FR05C0030I2 publication Critical patent/FR05C0030I2/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02Compounds containing any of the groups, e.g. carbazates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02Compounds containing any of the groups, e.g. carbazates
    • C07C281/04Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR05C0030C 1996-04-22 2005-07-05 HETEROCYCLIC AZAHEXANE DERIVATIVES WITH ANTIVIRAL ACTIVITY Active FR05C0030I2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH101896 1996-04-22
CH2997 1997-01-08
CH22397 1997-01-31
PCT/EP1997/001860 WO1997040029A1 (en) 1996-04-22 1997-04-14 Antivirally active heterocyclic azahexane derivatives

Publications (2)

Publication Number Publication Date
FR05C0030I1 FR05C0030I1 (en) 2005-08-12
FR05C0030I2 true FR05C0030I2 (en) 2007-04-27

Family

ID=27171723

Family Applications (1)

Application Number Title Priority Date Filing Date
FR05C0030C Active FR05C0030I2 (en) 1996-04-22 2005-07-05 HETEROCYCLIC AZAHEXANE DERIVATIVES WITH ANTIVIRAL ACTIVITY

Country Status (28)

Country Link
EP (1) EP0900210B1 (en)
JP (1) JP3174347B2 (en)
CN (3) CN1310905C (en)
AR (1) AR006720A1 (en)
AT (1) ATE288903T1 (en)
AU (1) AU706183B2 (en)
BR (1) BR9701877A (en)
CA (3) CA2510945C (en)
CY (1) CY2596B2 (en)
CZ (1) CZ296135B6 (en)
DE (2) DE122005000003I1 (en)
DK (1) DK0900210T3 (en)
EA (1) EA001794B1 (en)
ES (1) ES2238720T3 (en)
FR (1) FR05C0030I2 (en)
HK (2) HK1018788A1 (en)
HU (1) HU224125B1 (en)
IL (1) IL126381A (en)
LU (1) LU91189I2 (en)
MY (1) MY114457A (en)
NL (1) NL300203I2 (en)
NO (2) NO313330B1 (en)
NZ (3) NZ509045A (en)
PT (1) PT900210E (en)
SI (1) SI0900210T1 (en)
SK (1) SK285048B6 (en)
TW (1) TW409125B (en)
WO (1) WO1997040029A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087383A (en) * 1998-01-20 2000-07-11 Bristol-Myers Squibb Company Bisulfate salt of HIV protease inhibitor
US6251906B1 (en) 1998-05-15 2001-06-26 Abbott Laboratories Retroviral protease inhibiting compounds
JP2002515501A (en) * 1998-05-15 2002-05-28 アボット・ラボラトリーズ Inhibitory compounds of retroviral protease
US6096894A (en) * 1998-07-29 2000-08-01 Sumika Fine Chemicals Co., Ltd. Production method of 2-(p-alkylphenyl)pyridine compound
ATE239707T1 (en) * 1998-08-07 2003-05-15 Sumika Fine Chemicals Co Ltd 2-PHENYLPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
US6207715B1 (en) 1998-12-09 2001-03-27 American Home Products Corporation Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
US6335350B1 (en) 1998-12-09 2002-01-01 American Home Products Corporation Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
US6197803B1 (en) 1998-12-09 2001-03-06 American Home Products Corporation Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
US6255349B1 (en) 1998-12-09 2001-07-03 American Home Products Corporation Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
JP4222671B2 (en) 1999-02-15 2009-02-12 住友化学株式会社 Method for producing hydrazine derivative
IT1313664B1 (en) 1999-10-12 2002-09-09 Norpharma S P A PROCESS FOR THE PREPARATION OF AN ARY-PYRIDIN COMPOUND.
JP4278316B2 (en) * 2000-07-14 2009-06-10 住友化学株式会社 Method for producing hydrazine derivative
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
WO2004037790A1 (en) 2002-10-02 2004-05-06 Euticals Prime European Therapeuticals Spa Process for the preparation of aryl-piridyl compounds
ATE424198T1 (en) * 2002-12-06 2009-03-15 Vertex Pharma COMPOSITIONS CONTAINING A COMBINATION OF DIPHENYL UREA IMPDH INHIBITORS AND APOPTOSIS-INDUCING ANTICANCER AGENTS
ITMI20032338A1 (en) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph PHENYLTETRAZOLIC COMPOUNDS.
CN1980666B (en) * 2004-05-04 2011-03-30 布里斯托尔-迈尔斯斯奎布公司 Process for preparing atazanavir bisulfate and novel forms
ATE429417T1 (en) 2005-02-10 2009-05-15 Medivir Ab HIV PROTEASE INHIBITORS
EP2069303B1 (en) * 2006-07-21 2016-03-30 Gilead Sciences, Inc. Antiviral protease inhibitors
AU2008267048C1 (en) 2007-06-12 2013-01-17 Concert Pharmaceuticals, Inc. Azapeptide derivatives
WO2009130534A1 (en) * 2008-04-24 2009-10-29 Oxyrane (Pty) Ltd. Process for synthesizing atazanavir
EP2272830A1 (en) * 2009-06-18 2011-01-12 Esteve Química, S.A. Preparation process of an antivirally heterocyclic azahexane derivative
EP2272831A1 (en) 2009-06-26 2011-01-12 Prime European Therapeuticals S.p.A. Process for the preparation of arylpyridinyl compounds
WO2011037467A1 (en) 2009-09-28 2011-03-31 Stichting Katholieke Universiteit Atazanavir for treating inflammatory diseases
WO2011080562A1 (en) 2009-12-29 2011-07-07 Hetero Research Foundation Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
US20130005780A1 (en) * 2010-03-01 2013-01-03 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
CA2849546A1 (en) 2010-09-28 2012-04-05 Ratiopharm Gmbh Dry processing of atazanavir
WO2013014633A1 (en) * 2011-07-27 2013-01-31 Ranbaxy Laboratories Limited Process for preparation of atazanavir or its bisulfate salt
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104250224A (en) * 2013-06-28 2014-12-31 上海威智医药科技有限公司 Atazanavir fumarate and its preparation method and use
CN104163787A (en) * 2014-08-08 2014-11-26 山东威智医药工业有限公司 Preparation methods of Atazanavir and sulfate of Atazanavir
CN107459496B (en) * 2016-06-03 2022-07-19 华东理工大学 Use of thiazole derivatives for treating viral infections
JOP20180009A1 (en) 2017-02-06 2019-01-30 Gilead Sciences Inc Hiv inhibitor compounds
CN107245052A (en) * 2017-06-21 2017-10-13 连云港杰瑞药业有限公司 A kind of atazanavir preparation method
TWI829205B (en) * 2018-07-30 2024-01-11 美商基利科學股份有限公司 Anti-hiv compounds
CN109251165B (en) * 2018-10-02 2022-09-23 国药集团川抗制药有限公司 Atazanavir darby 4-aminobenzenesulfonate and preparation method thereof
CN109574916A (en) * 2018-12-29 2019-04-05 常州吉恩药业有限公司 The industrialized preparing process of atazanavir intermediate 2- [4- (2- pyridyl group) benzyl]-hydrazine carboxylic acid's tert-butyl ester
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113603634B (en) * 2021-08-06 2023-03-21 江苏八巨药业有限公司 Preparation method of atazanavir intermediate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
DK0521827T3 (en) * 1991-07-03 1996-11-11 Ciba Geigy Ag Pharmacologically active hydrazine derivatives and processes for their preparation
DK0604368T3 (en) * 1992-12-23 1997-02-24 Ciba Geigy Ag
DK0727419T3 (en) * 1992-12-29 2002-06-10 Abbott Lab Intermediates for the preparation of compounds that inhibit retroviral protease
US5461067A (en) * 1993-02-25 1995-10-24 Abbott Laboratories Retroviral protease inhibiting compounds

Also Published As

Publication number Publication date
JP3174347B2 (en) 2001-06-11
DE122005000003I1 (en) 2005-05-25
CZ337398A3 (en) 1999-01-13
FR05C0030I1 (en) 2005-08-12
EA001794B1 (en) 2001-08-27
CZ296135B6 (en) 2006-01-11
AR006720A1 (en) 1999-09-08
CN1616453A (en) 2005-05-18
HK1018788A1 (en) 2000-01-07
HK1075043A1 (en) 2005-12-02
CA2250840C (en) 2006-07-04
CN1082508C (en) 2002-04-10
HUP9901612A2 (en) 1999-08-30
LU91189I2 (en) 2005-10-03
NL300203I2 (en) 2005-11-01
JPH11511177A (en) 1999-09-28
DE69732483D1 (en) 2005-03-17
NO984900L (en) 1998-12-21
CA2568104C (en) 2009-08-04
EP0900210A1 (en) 1999-03-10
CY2596B2 (en) 2010-03-03
MY114457A (en) 2002-10-31
IL126381A (en) 2001-08-26
NO2005010I1 (en) 2005-05-02
NZ332118A (en) 2001-02-23
LU91189I9 (en) 2018-12-27
CN1319587A (en) 2001-10-31
AU2385997A (en) 1997-11-12
CN1216539A (en) 1999-05-12
HUP9901612A3 (en) 2000-06-28
ES2238720T3 (en) 2005-09-01
SI0900210T1 (en) 2005-08-31
NZ509045A (en) 2002-09-27
WO1997040029A1 (en) 1997-10-30
NO313330B1 (en) 2002-09-16
ATE288903T1 (en) 2005-02-15
CA2510945A1 (en) 1997-10-30
IL126381A0 (en) 1999-05-09
NL300203I1 (en) 2005-10-03
DK0900210T3 (en) 2005-05-02
CA2510945C (en) 2007-01-16
DE69732483T2 (en) 2005-07-28
CN1310905C (en) 2007-04-18
BR9701877A (en) 1998-09-29
NO984900D0 (en) 1998-10-21
TW409125B (en) 2000-10-21
SK285048B6 (en) 2006-05-04
SK145298A3 (en) 1999-06-11
CN1193010C (en) 2005-03-16
CA2568104A1 (en) 1997-10-30
EP0900210B1 (en) 2005-02-09
HU224125B1 (en) 2005-05-30
CA2250840A1 (en) 1997-10-30
PT900210E (en) 2005-06-30
NZ509046A (en) 2002-05-31
EA199800899A1 (en) 1999-10-28
AU706183B2 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
FR05C0030I2 (en) HETEROCYCLIC AZAHEXANE DERIVATIVES WITH ANTIVIRAL ACTIVITY
FR11C0023I2 (en) BENZIMIDAZOLE DERIVATIVES WITH ANTIHISTAMINIC ACTIVITY
NO996106D0 (en) 4 "- substituted - 9-deoxo-9A-AZA-9A-Homoerythromycin A derivatives
FI963539A (en) (4,4-Difluorobut-3-enylthio) -substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
NO994791D0 (en) Nicotinamide derivatives
TR199501209A2 (en) Urea derivatives
DK0966477T3 (en) 3'-N-oxide, 3'-N-dimethylamine, 9-oxime-erythromycin A derivatives
ITMI912182A0 (en) HETEROCYCLIC COMPOUNDS WITH ANTAGONISTIC ACTIVITY
FI954255A0 (en) 2,9-Diamino- and 2-amino-8-carbaomyl-4-hydroxy-alkanoic acid amide derivatives
DE69820102D1 (en) SUBSTITUTED CHROME DERIVATIVES
FR2763953B1 (en) 5'-DESOXY-CYTIDINE DERIVATIVES
ITMI921951A0 (en) IMIDAZOLE DERIVATIVES WITH II ANTAGONIST ACTIVITY
DE69820103D1 (en) SUBSTITUTED CHROME DERIVATIVES
FI955164A0 (en) Heterocyclic derivatives
FI970110A0 (en) Anti-Helicobacterial heterocyclic azolone derivatives
DE69208351T2 (en) HALOVINYL DERIVATIVES
PL327686A1 (en) Derivatives of @-amino 5,6-dichlorobenzimidazole exhibiting antiviral activity
FI950486A (en) Amide derivatives
BR9711110A (en) 4-substituted quinoline derivatives having fungicidal activity
NO961404D0 (en) 4 indolylpiperazinyl derivatives
MA23455A1 (en) 2-IMIDAZOLINE-5-ONES FUNGICIDE DERIVATIVES
ITMI930819A0 (en) HETEROBICYCLIC DERIVATIVES WITH FUNGICIDE ACTIVITY
MA26481A1 (en) ARYLSECOCHOLADIAN DERIVATIVES
MA23579A1 (en) 5-IMINO 2- IMIDAZOLINE FUNGICIDE DERIVATIVES
FR2511370B1 (en) 1,4-DIHYDROPYRIDINE DERIVATIVES WITH VASODILATOR AND HYPOTENSION ACTIVITY